Amphotericin B loaded SLN prepared with the coacervation technique

Journal of Drug Delivery Science and Technology

Volumn 20, Issue 3, 2010, Pages 187-191

  Bianco, M A ^a   Gallarate, M ^a   Trotta, M ^a   Battaglia, L ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Amphotericin B; Coacervation; Saccharomyces cerevisiae; SLN; Yeasts

Indexed keywords

AMPHOTERICIN B; FATTY ACID; LIPID; NANOPARTICLE; POTASSIUM; SODIUM CHLORIDE; STEARIC ACID;

ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; COACERVATION; CONTROLLED STUDY; ENCAPSULATION; IN VITRO STUDY; NONHUMAN; SACCHAROMYCES CEREVISIAE; SOLUTION AND SOLUBILITY; YEAST;

EID: 77953814080     PISSN: 17732247     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1773-2247(10)50028-5     Document Type: Article

References (26)

1. Müller R.H., Mäder K., Gohla S. - Solid Lipid Nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. - Eur. J. Pharm. Biopharm., 50, 161-177, 2000.
2. Müller R.H., Lucks J.S. - Arzneistoffträger aus festen Lipid-Teilchen, Feste Lipidnanosphären (SLN). - Eur. Patent No. 06055497, 16 May 1996.
3. Gasco M.R. - Method for producing solid lipid microspheres having a narrow size distribution. - US Patent No. 5250236, 5 October 1993.
4. Mumper R.J., Jay M. - Microemulsions as precursors to solid nanoparticles. - US Patent No. 7153525, 26 December 2006.
5. Siekmann B., Westesen K. - Investigation on solid lipid nanoparticles prepared by precipitation in o/w emulsion. - Eur. J. Pharm. Biopharm., 43, 104-109, 1996.
6. Schubert M.A., Müller-Goymann C.C. - Solvent injection as a new approach for manufacturing lipid nanoparticles - evaluation of the method and process parameters. - Eur. J. Pharm. Biopharm., 55, 125-131, 2003.
7. Trotta M., Cavalli R., Carlotti M.E., Battaglia L., Debernardi F. - Solid lipid micro-particles carrying insulin formed by solvent-in-water emulsion-diffusion technique. - Int. J. Pharm., 288, 281-288, 2005.
8. Battaglia L., Trotta M., Gallarate M., Carlotti M.E., Zara G.P., Bargoni A. - Solid lipid nanoparticles formed by solvent-in-water emulsion diffusion technique: development and influence of insulin stability. - J. Microencaps., 14, 672-684, 2007.
9. Gallarate M., Trotta M., Battaglia L., Chirio D. - Preparation of solid lipid nanoparticles from w/o/w emulsions: preliminary studies on insulin encapsulation. - J. Microencaps., 3, 1-9, 2008.
10. Battaglia L., Gallarate M., Cavalli R., Trotta M. - Solid lipid nanoparticles produced through a coacervation method. - J. Microencaps., 27, 78-85, 2010.
11. Haynes M.P., Chong P.L.-G., Buckley H.R., Pieringer R.A. - Fluorescence studies on the molecular action of amphotericin B on susceptible and resistant fungal cells. - Biochem., 35, 7983-7992, 1996.
12. Andres, E., Tiphine, M., Letscher-Bru, V., Herbrecht, R. - Nouvelles formes lipidiques de l'amphotéricine B. Revue de la littérature. - Rev. Med. Int., 22, 141-150, 2001.
13. Hann I., Prentice H. - Lipid-based amphotericin B: a review of the last 10 years of use. - Int. J. Antimicrob. Agents, 17, 161-169, 2001.
14. HILLERY A. - Supramolecular lipidic drug delivery systems: from laboratory to clinic. A review of the recently introduced commercial liposomal and lipid-based formulations of amphotericin B. - Adv. Drug Deliv. Rev., 24, 345-363, 1997.
15. Peman J., Canton E., Espinel-Ingroff A. - Antifungal drug resistance mechanisms. - Expert Rev. Anti Infect. Ther., 7, 453-460, 2009.
16. Adams M., Kwon G. - Relative aggregation state and hemolytic activity of amphotericin B encapsulated by poly(ethylene oxide)-block-poly(N-hexyl-l- aspartamide)-acyl conjugate micelles: effects of acyl chain length. - J. Control. Rel., 87, 23-32, 2003.
17. Vandermeulen G., Rouxhet L., Arien A., Brewster M.E., Preat V. - Encapsulation of amphotericin B in poly(ethylene glycol)-block-poly(ε- caprolactone-co-trimethylenecarbonate) polymeric micelles. - Int. J. Pharm., 309, 234-240, 2006.
18. Legrand P., Romero E., Devissaguet J.-P., Eleazar Cohen B., Bolard J. - Effects of aggregation and solvent on toxicity of amphotericin B to human erythrocytes. - Antimicrob. Agents Chemother., 36, 2518-2522, 1992.
19. Gruszecki W.I., Gagos M., Herec M. - Dimers of polyene antibiotic amphotericin B detected by means of fluorescence spectroscopy: molecular organization in solution and in lipid membranes. - J. Photochem. Photobiol. B: Biology, 69, 49-57, 2003.
20. Bolard J., Legrand P., Heitz F., Cybulska B. - One-sided action of amphotericin B on cholesterol-containing membranes is determined by its self-association in the medium. - Biochem., 30, 5707-5715, 1991.
21. Brajtburg J., Elberg S., Kobayashi G.S., Bolard J. - Amphotericin B incorporated into egg lecithin-bile salt mixed micelles: molecular and cellular aspects relevant to therapeutic efficacy in experimental mycoses. - Antimicrob. Agents Chemother., 38, 300-306, 1994.
22. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A2(22). - In: National Committee for Clinical Laboratory Standards, Wayne, Pa., 2002.
23. Swinne D., Watelle M., Nolard N. - In vitro activities of voriconazole, fluconazole, itraconazole and amphotericin B against non Candida albicans yeast isolates. - Rev. Iberoam. Micol., 22, 24-28, 2005.
24. Takemoto K., Yamamoto Y., Ueda Y. - Evaluation of antifungal pharmacodynamic characteristics of Ambisome against Candida albicans. - Microbiol. Immunol., 50, 579-586, 2006.
25. Tiyaboonchai W., Woiszwillo J., Russell Middaugh C. - Formulation and characterisation of amphotericin b-polyethylenimine-dextran sulfate nanoparticles. - J. Pharm. Sci., 90, 902-914, 2000.
26. Peng H.S., Liu X.J., Lu G.X., Sun B., Kong Q.F., Zhai D.X., Wang Q., Zhao W., Wang G.Y., Wang D.D., Li H.L., Jin L.H., Kostulas N. - Voriconazole into PLGA nanoparticles: Improving agglomeration and antifungal efficacy. - Int. J. Pharm., 352, 29-35, 2008.